Compare ARK Genomic Revolution ETF (ARKG) vs Macy's Inc (M) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Macy's Inc — how do they compare? ARK Genomic Revolution ETF trades at $41, while Macy's Inc trades at $22.64 (market cap $5.96B). The key difference: Macy's Inc pays a 3.38% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Macy's Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | M | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $25.96 |
52-Week Low | $23.09 | $11.90 |
Market Cap | — | $5.96B |
Enterprise Value | — | $9.77B |
Dividend Yield | — | 3.38% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Macy's (M) trades at $22.64, down 0.18% on the day, with a bullish technical signal and strong recent earnings beats. The stock shows attractive valuation metrics including a P/E of 9.36 and P/S of 0.27, while profitability metrics like ROE of 14.36% indicate efficient capital use. Recent news highlights Berkshire Hathaway's new 3.04 million-share stake and the company's 'Bold New Chapter' strategy driving comparable sales growth.
The outlook for Macy's is cautiously optimistic with a consensus price target of $24.83 offering ~10% upside. Key opportunities include luxury brand expansion and digital transformation, while risks involve margin pressure from restructuring and competitive retail headwinds. The stock presents a value opportunity if turnaround execution continues successfully.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Macy's Inc
Founded in 1858 and based in New York City, Macy's operates 570 stores under the Macy's nameplate, 58 stores under the Bloomingdale's nameplate, and 160 freestanding Bluemercury specialty beauty stores (as of the end of fiscal-year 2021). Macy's also operates e-commerce sites and licenses two Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances comprised 59% of Macy's 2021 sales.
Read more on M →
